Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

Launched by NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH) · Apr 28, 2005

Keywords

ClinConnect Summary

This clinical trial is looking to better understand mood and anxiety disorders by studying both patients who have these conditions and healthy volunteers. The goal is to carefully screen participants to gather important information about their health and experiences. By collecting data through interviews, medical exams, and brain scans, researchers hope to learn more about how these disorders affect people and how they can be treated.

To be eligible for the study, participants must be between the ages of 3 and 99 and able to understand what the study involves. They will go through a thorough evaluation that includes a psychiatric interview and various medical tests. Participants will not be accepted if they have had serious substance use issues in the last three months. Overall, this study is a chance for individuals with mood or anxiety disorders, as well as healthy volunteers, to contribute to important research that could improve understanding and treatment of these conditions.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Subjects ages 3 to 99 may enroll in the protocol.
• • Subjects must be competent to comprehend the purpose of the screening process and to provide written informed consent and be willing to participate in NIMH IRB approved research protocols. Minors will be asked to assent and their parents will sign the consent form.
• • Subjects will undergo an evaluation which may include a psychiatric interview, medical (including Tanner staging for minors), neurological, and laboratory examinations (as appropriate such as EKG, EEG, renal and liver function tests, serum electrolytes, urinalysis, HIV, hepatitis A, B, and C, lupus anticoagulant, anticardiolipin (aCL) antibodies, anti-b2glycoprotein-I antibodies, PT/PTT, blood levels of psychotropic drugs, pregnancy testing, and urine drug screen for the presence of psychoactive drugs and drugs of abuse).
• EXCLUSION CRITERIA:
• • Current alcohol or substance use or dependence (excluding nicotine) within the past 3 months of sufficient magnitude to require independent, concurrent treatment intervention (e.g. antabuse or opiate treatment, but not including self-help groups).
• • Whether the minor lives with both parents or one parent, the parent(s) he/she lives with must have legal custody. If a parent has shared custody, both parents must consent to participate in this protocol.